Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand

Diabetes and Metabolism

Volumn 34, Issue 3, 2008, Pages 283-289

  Jiamjarasrangsi, W ^a   Sangwatanaroj, S ^a   Lohsoonthorn, V ^a   Lertmaharit, S ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

ALT; AST; Diabetes risk; Impaired fasting glucose; Longitudinal study; Prognostic value; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPLOYEE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODIC MEDICAL EXAMINATION; RISK ASSESSMENT; THAILAND; UNIVERSITY HOSPITAL; WORKER;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HOSPITALS, UNIVERSITY; HUMANS; LIVER; MALE; MIDDLE AGED; PERSONNEL, HOSPITAL; RISK FACTORS; THAILAND;

EID: 49849089717     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.01.009     Document Type: Article

References (19)

1. Sattar N., McConnachie A., Ford I., Gaw A., Cleland S.J., Forouhi N.G., et al. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56 (2007) 984-991
2. Schindhelm R.K., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., et al. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med 24 (2007) 430-435
3. Wannamethee S.G., Shaper A.G., Lennon L., and Whincup P.H. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28 (2005) 2913-2918
4. André P., Balkau B., Born C., Royer B., Wilpart E., Charles M.A., et al. Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The DESIR. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome). Diabetes Metab 31 (2005) 542-550
5. Nannipieri M., Gonzales C., Baldi S., Posadas R., Williams K., Haffner S.M., et al. Mexico City diabetes study. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28 (2005) 1757-1762
6. Lee D.H., Silventoinen K., Jacobs Jr. D.R., Jousilahti P., and Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20, 158 middle-aged men and women. J Clin Endocrinol Metab 89 (2004) 5410-5414
7. Nakanishi N., Suzuki K., and Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27 (2004) 1427-1432
8. Sattar N., Scherbakova O., Ford I., O'Reilly D.S., Stanley A., Forrest E., et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 53 (2004) 2855-2860
9. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., Kempf J., et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 53 (2004) 2623-2632
10. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
11. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
12. Schindhelm R.K., Dekker J.M., Nijpels G., Heine R.J., and Diamant M. No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study. Diabetes Care 28 (2005) 2812
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 Suppl. 1 (2005) s37-s42
14. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
15. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure and national heart, lung, and blood institute; national high blood Pressure education program coordinating committee. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
16. Expert Panel on Detection. Evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
17. Altman D.G. Practical statistics for medical research (1997), Chapman & Hall, London
18. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 79 (1989) 340-349
19. Cugati S., Wang J.J., Rochtchina E., and Mitchell P. Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Med J Aust 186 (2007) 131-135